scPharmaceuticals Inc logo

scPharmaceuticals Inc

NEW
NAS:SCPH (USA)  
$ 4.46 +0.03 (+0.68%) 12:08 AM EST
At Loss
P/B:
17.15
Market Cap:
$ 223.13M
Enterprise V:
$ 224.24M
Volume:
301.86K
Avg Vol (2M):
282.61K
Trade In:
Volume:
301.86K
At Loss
Avg Vol (2M):
282.61K

Business Description

Description
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Name Current Vs Industry Vs History
Cash-To-Debt 0.93
Equity-to-Asset 0.14
Debt-to-Equity 4.47
Debt-to-EBITDA -0.8
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.68
Distress
Grey
Safe
Beneish M-Score 7.13
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.34
9-Day RSI 56
14-Day RSI 50.87
6-1 Month Momentum % 2.01
12-1 Month Momentum % -11.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.84
Quick Ratio 3.66
Cash Ratio 2.98
Days Inventory 491.17
Days Sales Outstanding 67.27
Days Payable 174.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.6
Shareholder Yield % -4.36

Financials

SCPH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SCPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

scPharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 24.048
EPS (TTM) ($) -1.56
Beta 0.19
Volatility % 55.42
14-Day RSI 50.87
14-Day ATR ($) 0.25062
20-Day SMA ($) 4.277
12-1 Month Momentum % -11.28
52-Week Range ($) 3.24 - 6.71
Shares Outstanding (Mil) 50.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

scPharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

scPharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

scPharmaceuticals Inc Frequently Asked Questions

What is scPharmaceuticals Inc(SCPH)'s stock price today?
The current price of SCPH is $4.46. The 52 week high of SCPH is $6.71 and 52 week low is $3.24.
When is next earnings date of scPharmaceuticals Inc(SCPH)?
The next earnings date of scPharmaceuticals Inc(SCPH) is .
Does scPharmaceuticals Inc(SCPH) pay dividends? If so, how much?
scPharmaceuticals Inc(SCPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1